{"filings":[{"id":95419,"accession_number":"0001185185-26-001231","cik":1784440,"company_name":"BioScience Health Innovations, Inc.","ticker":"BHIC","form_type":"8-K","filed_at":"2026-04-02T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Bioscience Health Innovations board member Justin Earl resigns; Daniel Schmidt appointed director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Justin Earl resigned from the board effective April 1, 2026, with no disagreement on company matters.","Daniel Schmidt appointed as director effective April 1, 2026, filling the vacancy.","Schmidt has served as the company's Chief Technology Officer since its inception."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124920,"accession_number":"0001185185-25-001456","cik":1784440,"company_name":"BioScience Health Innovations, Inc.","ticker":"BHIC","form_type":"8-K","filed_at":"2025-10-16T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"BioScience Health Innovations enacts 4-for-1 reverse stock split effective Sept. 10, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split ratio of 4 old shares to 1 new share, approved by board and majority stockholder written consent.","Effective September 10, 2025; no other changes to the Certificate of Incorporation.","Split does not affect stockholders' proportional ownership or voting rights."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177875,"accession_number":"0001185185-25-000186","cik":1784440,"company_name":"BioScience Health Innovations, Inc.","ticker":"BHIC","form_type":"8-K","filed_at":"2025-03-17T23:59:59+00:00","items":["5.03"],"status":"ready","headline":"Nowtransit changes name to BioScience Health Innovations, Inc. effective Feb 21, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company name changed from Nowtransit, Inc. to BioScience Health Innovations, Inc. effective February 21, 2025.","Name change approved by Board of Directors under Nevada law; no impact on stockholder rights.","Bylaws amended and restated solely to reflect the new corporate name.","Certificate of amendment to Restated Certificate of Incorporation filed with Nevada Secretary of State."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229338,"accession_number":"0001185185-24-000654","cik":1784440,"company_name":"BioScience Health Innovations, Inc.","ticker":"BHIC","form_type":"8-K/A","filed_at":"2024-06-25T23:59:59+00:00","items":["1.01","2.01","5.03","9.01","4.01","3.02","5.02","5.06"],"status":"ready","headline":"Nowtransit completes reverse merger with Best Labs; issues 34M shares (85.4%) for supplement business","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Issued 34,371,100 shares (85.39% of post-closing shares) to Best Labs shareholders for all of Best's shares; deal closed March 10, 2023.","Company exited online delivery business; now markets Be On-Guard mouth spray, nasal spray, surface cleaner, brain support supplements, and methylene blue products.","Zero employees as of March 13, 2023; supply chain managed by Ageless Holdings LLC (CEO is managing member).","Filing addresses shell status; company remains OTC Pink voluntary filer, subject to penny stock rules and limited liquidity.","Holds provisional patent 63/560,474 for methylthioninium salt compositions; plans to file PCT application by March 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229339,"accession_number":"0001185185-24-000582","cik":1784440,"company_name":"BioScience Health Innovations, Inc.","ticker":"BHIC","form_type":"8-K","filed_at":"2024-05-22T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Nowtransit dismisses Spiegel, appoints Mac as auditor after FY2022 going concern","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Spiegel dismissed as auditor effective March 10, 2023; Mac appointed March 15, 2023.","Spiegel's FY2022 report included an explanatory paragraph about substantial doubt as a going concern.","No reportable events or disagreements with Spiegel during the relevant periods.","Spiegel provided a letter to the SEC agreeing with the company's disclosures, filed as Exhibit 16.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321551,"accession_number":"0001185185-23-000249","cik":1784440,"company_name":"BioScience Health Innovations, Inc.","ticker":"BHIC","form_type":"8-K","filed_at":"2023-03-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Nowtransit appoints John Chymboryk as CFO effective March 21, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John Chymboryk appointed Chief Financial Officer, effective immediately on March 21, 2023.","Biographical details for Mr. Chymboryk were previously disclosed in a Form 8-K filed March 16, 2023.","The appointment was filed under Item 5.02 of Form 8-K."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321550,"accession_number":"0001185185-23-000223","cik":1784440,"company_name":"BioScience Health Innovations, Inc.","ticker":"BHIC","form_type":"8-K","filed_at":"2023-03-16T23:59:59+00:00","items":["2.01","3.02","5.02","5.03","5.06","1.01"],"status":"ready","headline":"Nowtransit completes reverse merger with Best Labs; new CEO and board appointed","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Nowtransit issued 34,371,100 shares (85.39% of outstanding) for 100% of Best Labs common stock.","Darren Lopez appointed CEO and director; John Chymboryk appointed director; Justin Earl resigned as officer.","Fiscal year changed from August 31 to December 31 to align with Best Labs.","Company ceased being a shell company upon closing of the share exchange."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321549,"accession_number":"0001185185-23-000148","cik":1784440,"company_name":"BioScience Health Innovations, Inc.","ticker":"BHIC","form_type":"8-K","filed_at":"2023-02-17T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Nowtransit to issue 85.39% stake for Best Labs acquisition in share exchange","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Nowtransit acquires Best Labs via share exchange; Best shareholders receive 34.37M shares (85.39% post-exchange) for 100% of Best.","Justin Earl resigns as CEO; Darren Lopez (Best CEO) becomes CEO of combined company.","Justin Earl remains on board; Darren Lopez and John Chymboryk appointed directors.","Closing conditions include audited financials and Form 10 filing; target close by Feb 24, 2023.","Best shareholders subject to 12-month lock-up and no registration for 12 months; shares restricted."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":339655,"accession_number":"0001185185-22-001369","cik":1784440,"company_name":"BioScience Health Innovations, Inc.","ticker":"BHIC","form_type":"8-K","filed_at":"2022-11-29T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Nowtransit sells 40,000 Series A convertible preferred shares for $40,000 gross proceeds","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 40,000 Series A convertible preferred shares at $1.00/share to an accredited investor, raising $40,000 gross before expenses.","Each Series A share converts into 3 shares of common stock at holder's election, subject to 4.99% beneficial ownership limitation.","The 4.99% limitation may be increased to 9.99% upon 61 days' notice.","Proceeds will be used for working capital and general corporate purposes (implied)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":431104,"accession_number":"0001185185-21-001231","cik":1784440,"company_name":"BioScience Health Innovations, Inc.","ticker":"BHIC","form_type":"8-K","filed_at":"2021-09-01T23:59:59+00:00","items":["5.01","5.02"],"status":"ready","headline":"Nowtransit Inc. change of control: Justin Earl acquires 51.3% stake, becomes President and sole director","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Justin Earl purchased 2,800,000 shares (51.3% of common stock) from former majority shareholder Ivan Homici for $28,000 on April 2, 2021.","Ivan Homici resigned as director, President, Treasurer, and Secretary on July 29, 2021; Justin Earl replaced him in all roles.","Justin Earl, age 47, previously served as President of Strategic Junction since 2011, focusing on business continuity and risk management.","No related party transactions or other arrangements existed between the company and Mr. Earl."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}